Novavax’s stock slides 16% after FDA puts clinical hold on COVID and flu vaccine candidates

Date:

October 16, 2024

Novavax Inc.’s stock tumbled 16% early Wednesday after the company said the FDA has placed a clinical hold on its COVID-19-and-flu combination and stand-alone flu vaccine candidates, following a case of motor neuropathy in a participant in a mid-stage trial.

Source link

Amazon, Google make dueling nuclear investments to power data centers with clean energy

Leeds duo Daniel James and Manor Solomon return from injury absences

Alexandra Williams

Alexandra Williams is a writer and editor. Angeles. She writes about politics, art, and culture for LinkDaddy News.

Novavax’s stock slides 16% after FDA puts clinical hold on COVID and flu vaccine candidates

Recent posts

Amazon hit with $5.9 million fine as California says it failed to disclose quotas to workers

These stocks stand to benefit if a Trump White House adopts a tougher stance on China

Trump floats manufacturing ambassador, while his Deere tariff threat draws flak from Mark Cuban

Boeing’s credit rating not immediately impacted by strike, says S&P

Boeing’s confidence in Starliner ‘speaks volumes,’ says former NASA astronaut

Want solar panels and clean-energy home improvements? Here’s what the IRS paid people for upgrades last year.

Earnings Watch: Walmart reports this week. Its ‘resilience’ will be tested amid signs of consumer slowdown, analyst says

Treasurys poised to end July with longest stretch of monthly rallies in years

Chipotle’s stock rallies as renewed focus on quicker service helps second-quarter results

Oil prices rise over 3% as Israel weighs response to Iran missile attack

After its August selloff, the U.S. dollar may face more downside risk ahead

Oil prices attempt to stabilize after ending at 7-week lows

Geo Group and CoreCivic move guidance in opposite directions, a day after both prison stocks soared

Hedge-fund manager who could be Trump Treasury secretary says tariffs can be negotiated lower

Lyft told drivers they could make more than $30 an hour. The FTC says it deceived them.

Related articles

Trump’s choice of Dr. Oz to oversee Medicare and Medicaid could be ‘devastating’ for millions of Americans

Buy gold after its pullbacks — because it may hit $3,000 in 2025

Bitcoin sits near record high. More good news for investors: It’s now less volatile.

RFK Jr. may start a food and drug ‘culture war.’ Investors are running for cover.

Here’s what bond and gold traders are signaling about Russia’s nuclear shift

Stock market ‘finally paying more attention to tariffs’ as a potential headwind

Investors are bracing for higher-for-even-longer interest rates

RFK Jr. is not a fan of weight-loss drugs or vaccines. Stocks are tanking.

Company

Follow us